A new meta-analysis shows meaningful differences among FDA-approved antipsychotic adjuncts for MDD, with lumateperone showing the strongest efficacy and aripiprazole the best overall acceptability.

Kanghong Pharmaceutical and Vanotech Ltd. today announced the successful completion of a Phase 2b clinical trial evaluating KH607 in adults with major depressive disorder (MDD). HIGHLIGHTS Phase 2b ...

Major Depressive Disorder (MDD) is far from a cookie-cutter diagnosis. Different patients report suffering from different subsets of symptoms, yet most are ultimately prescribed the same first-line ...

Among people with major depressive disorder, treatment with semaglutide reduces the perceived cost of effort and improves motivation.

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major ...

A new study uses real-time fMRI neurofeedback to help depression patients reduce rumination by training specific brain ...

Before your first psychiatrist appointment for major depressive disorder, you can do many things to prepare. By planning ahead, you’re doing everything on your end to make sure you have a smooth ...

Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a ...

I talk a lot about what it means for me to be disabled, both with my friends and in the workplace. So talking about depression is quite common. I do have a physical disability: a hypermobility ...